With Patients Accessing Their Own Electronic Health Records, How Can Care Orgs Handle Patient Data Safely & Securely?

 

Last year, the 21st Century Cures Act changed how patients could access their health data. The new rule, aimed to prevent information blocking of all electronic health information (EHI), gave patients the power to use, access, and share all of their health information. By empowering patients to access their own electronic health records and overall health data, the act sought to drive further innovation and research and facilitate the exchange of important health data. However, this has made it important for healthcare practitioners to handle electronic health information safely and securely.

To ensure minimum roadblocks in the exchange of electronic health information, the new rule has banned healthcare practitioners from blocking patients from accessing their medical information — or choosing to share it with third parties that they themselves have approved. However, experts believe that sharing access to such comprehensive electronic health records needs to be done in a safe and secure manner.

Bart Howe, who serves as the President of AHIOS, which provides training to handle patient information appropriately, explained why health practitioners must handle electronic health information safely and securely during the five-day premier health conference HIMSS 2023.

 

Bart’s Thoughts

“For the rest of this year and beyond, I expect we’ll continue to see a lot of change. That’ll be the one constant throughout the evolution of our industry. Technology’s changing, regulations are changing, and our organizations are typically — the ones that we service — are typically focused on serving the patients, which is where we want them focused. Whereas AHIOS and our member organizations need to make sure that we are equipping them with both the tools, the technology, the processes and the people, in order to facilitate the exchange of information that’s important to delivering the highest quality care at the right location, at the right time.

One of the things that we are learning as an industry, kind of the hard way, is that the information that resides within the healthcare ecosystem is the property of the patients. So getting that information into the hands of the patients is easier said than done. That’s one of the things that our member organizations do all day every day, is deliver medical records to individuals and other participants within the ecosystem who have the rights to access that information. And one of the challenges that we have is making sure that we are navigating both access and privacy. Those are two very important concerns. We wanna make sure we’re delivering access where we can, and where it’s important in facilitating ease of information exchange, while also making sure that we’re protecting that information and creating the right privacy and safeguards around who gets access to that information.”

Article written by Aarushi Maheshwari.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More